Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
CA 2673615 C · Owner: Villhauer, Edwin Bernard · Inventors: Balkan, Bork; Hughes, Thomas Edward; Villhauer, Edwin Bernard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a combination which comprises a DPP-IV inhibitor which is (S)-1-(3-hydroxy-1--adamantyl)aminoacetyl-2-cyano-pyrrolidine in free form or in acid addition salt form and metformin or a pharmaceutically acceptable salt thereof for simultaneous separate or sequential use in the prevention delay of progression or treatment of conditions mediated by dipeptidylpeptidase-IV (DPP-IV) in particular diabetes, more especially type 2 diabetes mellitus conditions of impaired glucose tolerance (IGT) conditions of impaired fasting plasma glucose metabolic acidosis, ketosis, arthritis obesity and osteoporosis; and the use of such combination for the cosmetic treatment of a mammal in …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 19, 2001 and granted July 16, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.